iii After 26m 2004 17m, 2003 nil unreimbursed by insurers relating to macrotextured knee revisions.
17m was spent in 2003 on Centerpulse costs.
iv Discontinued operations accounted for14m 2004 14m, 2003 59m ofinvesting activities.
v The significant differences between the cash flow statement presented above and that required under accounting principles generally accepted in the US are setout in Note 39 ofthe Notes tothe Group Accounts.
